OPINION article

Front. Microbiol., 02 September 2014

Sec. Microbiotechnology

Volume 5 - 2014 | https://doi.org/10.3389/fmicb.2014.00454

Rhamnolipid biosurfactants—past, present, and future scenario of global market

  • 1. Section for Sustainable Biotechnology, Department of Biotechnology, Chemistry and Environmental Engineering, Aalborg University Copenhagen, Denmark

  • 2. Technology Futures Institute, School of Science & Engineering, Teesside University Tees Valley, UK

Rhamnolipids—brief outline

Biosurfactants, widely known as surface-active agents of biological origin, have carved a niche for themselves in the market due to their unique environment-friendly properties. They have come a long way since first biosurfactant “surfactin” was purified and characterized by Arima et al. (1968). Biosurfactants have been researched thoroughly and satisfactorily since then by many research groups across the world yet there are aspects that elude our understanding. There are five major categories of biosurfactants viz. glycolipids, phospholipids and fatty acids, lipopeptides and lipoproteins, polymeric biosurfactants and particulate biosurfactants that have found applications in agricultural, pharmaceutical, food, cosmetics, and detergent industries. Data reveals there are more than 250 patents obtained on these wonder biodegradable molecules so far (Shete et al., 2006; Rahman and Gakpe, 2008). It has also been observed that microbial biosurfactants are advantageous over plant-based surfactants because of the scale-up capacity, rapid production, and multi-functional properties. Several plant-based biosurfactants for example saponins, lecithins, and soy proteins have excellent emulsification properties but are expensive to produce at industrial scale and have other debatable issues such as solubility and hydrophobicity (Xu et al., 2011).

Among the various categories of biosurfactants the glycolipid biosurfactants “rhamnolipids” stand apart. Rhamnolipid, primarily a crystalline acid, is composed of β-hydroxy fatty acid connected by the carboxyl end to a rhamnose sugar molecule. Rhamnolipids are predominantly produced by Pseudomonas aeruginosa and classified as: mono and di-rhamnolipids. Other Pseudomonas species that have been reported to produce rhamnolipids are P. chlororaphis, P. plantarii, P. putida, and P. fluorescens. Some bacteria are known to produce only mono-rhamnolipids while some produce both. The ratio of mono and di-rhamnolipid can also be controlled in the production method. There are enzymes available that can convert mono-rhamnolipids into di-rhamnolipids. In 1984, the first patent for the production of rhamnolipids was filed by Kaeppeli and Guerra-Santos (US 4628030) and obtained in 1986 for their work on Pseudomonas aeruginosa DSM 2659 (Kaeppeli and Guerra-Santos, 1986). Subsequently, Wagner et al. filed a patent (US 4814272) in 1985 for the biotechnical production of rhamnolipids from Pseudomonas sp. DSM 2874 and obtained the same in 1989 (Wagner et al., 1989). In the past close to three decades, there has been a great body of research work carried on rhamnolipids revealing many of their astonishing applications and making them reach the pinnacle of popularity among all the categories of biosurfactants in the global market. The reason behind the current global interest in rhamnolipid production owes to their broad range of applications in various industries along with many spectacular “eco-friendly” properties.

The current critique articulates to present opinion on rhamnolipid research and is an attempt to retrospect what brings rhamnolipids in the forefront. This article is a bird's-eye view on a timeline of rhamnolipids story so far and also a critical analysis on why despite so many patents and research work rhamnolipids still do not rule the global biosurfactant market.

Inimitable applications of rhamnolipids

Over the years rhamnolipids are becoming broadly pertinent in various industries and are posing a serious threat to the synthetic surfactants. Before venturing into the current production economics of rhamnolipids it is imperative to evaluate the major applications of rhamnolipids that make them noticeable among other biosurfactants. A list of five major applications of rhamnolipids that cater to the wide range of industrial demands includes:

  • Bioremediation and enhanced oil recovery (EOR): Rhamnolipids show excellent emulsification properties, efficiently remove crude oil from contaminated soil and facilitate bioremediation of oil spills (Rahman et al., 2003; Costa et al., 2010).

  • Pharmaceuticals and therapeutics: Rhamnolipids show low toxicity, surface active properties and antimicrobial activities against several microbes (Bacillus cereus, Micrococcus luteus, Staphylococcus aureus, Listeria monocytogenes) thereby showing promising applications in pharmaceuticals and therapeutics (Magalhaes and Nitschke, 2013).

  • Cosmetics: Rhamnolipid as an active ingredient is found to be effective for several skin treatments i.e., wound healing with reduced fibrosis, cure of burn shock, treatment of wrinkles hence are in demand in the health and beauty industry (Piljac and Piljac, 2007).

  • Detergents and cleaners: Rhamnolipids are natural emulsifiers and surface active agents leading to their wide spread usage in detergent compositions, laundry products, shampoos and soaps (Parry et al., 2013).

  • Agriculture: Rhamnolipids are already used for soil remediation for improving soil quality and are now further getting explored for plant pathogen elimination, for aiding the absorption of fertilizers and nutrients through roots and as biopesticides (Sachdev and Cameotra, 2013).

Biosurfactant producing companies—with focus on rhamnolipids

Rhamnolipids are highly applicable in various activities with some researchers advancing the technology from laboratory to higher scale. However, there still are very limited companies in the field which are producing biosurfactants at a marketable scale. We tried to compile a list of biosurfactant producing companies around the globe (Table 1). The compilation evidently defines which biosurfactants are mostly researched and produced at higher scale.

Table 1

S. No.CompanyLocation(s)Product(s)Focus on
1TeeGene BiotechUKRhamnolipids and LipopeptidesPharmaceuticals, cosmetics, antimicrobials and anti-cancer ingredients
2AGAE Technologies LLCUSARhamnolipids (R95, an HPLC/MS grade rhamnolipid)Pharmaceutical, cosmeceutical, cosmetics, personal care, bioremediation (in situ & ex situ), Enhanced oil recovery (EOR)
3Jeneil Biosurfactant Co. LLCUSARhamnolipids (ZONIX, a bio-fungicide and RECO, a rhamnolipid used in cleaning and recovering oil from storage tanks)Cleaning products, EOR
4Paradigm Biomedical Inc.USARhamnolipidsPharmaceutical applications
5Rhamnolipid Companies, Inc.USARhamnolipidsAgriculture, cosmetics, EOR, bioremediation, food products, pharmaceutical
6Fraunhofer IGBGermanyGlycolipids, Cellobiose lipids, MELsCleansing products, shower gels, shampoos, washing-up liquids, pharmaceutical (bioactive properties)
7Cognis Care ChemicalsChina, Germany, USAAlkyl polyglucoside APG®, Plantacare 1200 GLY (green surfactant for use in oral-dental formulations), Rheocare TTA (for cleansing formulations)Used in formulations for household cleaners, bath/shower gels, dish washing, laundry detergents and in agrochemicals
8Saraya Co. Ltd.JapanSophorolipids (Sophoron, a low-foam dishwasher detergent)Cleaning products, hygiene products
9Ecover BelgiumBelgiumSophorolipidsCleaning products, cosmetics, bioremediation, pest control, pharmaceuticals
10Groupe SolianceFranceSophorolipidsCosmetics
11MG Intobio Co. Ltd.South KoreaSophorolipids (Sopholine—functional soap with Sophorolipids secreted by yeasts)Beauty and personal care, bath supplies e.g., soaps with new functions
12Synthezyme LLCUSASophorolipidsCleaning products, cosmetics, food products, fungicides, crude oil emulsification
13Allied Carbon Solutions (ACS) LtdJapanSophorolipids (ACS-Sophor—first bio-based surfactant from Indian mahua oil)Agricultural products, ecological research
14HenkelGermanySophorolipids, Rhamnolipids, Mammoslyerthritol lipidsGlass cleaning products, laundry, beauty products
15Lion CorporationJapanMethyl ester sulfonates (MES)Detergents formulations, cleaning products
16Lipo ChemicalsUSALipomulse Luxe (high-temperature resistance emulsifier)Skin care, sun-lotions hair care formulations, thickening polymers, rheological modifiers, natural gums
17Kaneka Co.JapanSophorose lipidsCosmetics and toiletry products

Biosurfactant producing companies around the globe.

Availability of feedstock and its impact on biosurfactants

Biodiesel is produced by the trans-esterification of vegetable oils and fats with methanol in the presence of a catalyst. Glycerol is received as a by-product from this reaction. The production of 1 ton biodiesel generates about 100 kg of glycerol. Hence, the European biodiesel industry might release about 600 Kiloton glycerol per year with an increasing tendency in Europe and worldwide. Oversupply of glycerol, essentially due to increasing biodiesel production, leads to decreasing prices and weak markets.

The price of pure glycerol varied from $0.50 to $1.50/lb and crude glycerol from $0.04/kg to $0.33/kg over the past few years. The price of glycerol in the market will continue to drop in such an over saturated market. Currently, the main supply of glycerol coming into the market is from the rapidly growing biodiesel industry. Estimated production of glycerol would reach 5.8 billion pounds in 2020. This is due to demand of biodiesel that is projected at 8 billion gallons in 2020 (Ayoub and Abdullah, 2012). Hence new outlets for glycerol are urgently needed, particularly in the case of crude glycerol released by the biodiesel processes. As glycerol is a nontoxic, edible, biodegradable compound, it will provide important environmental benefits to the new platform products.

In case of biosurfactant production, dramatically rising in biodegradable, non-toxic and eco-friendly alternative for chemical surfactants and the re-discovered opportunity of biosurfactants that gave rise to invention and investment ahead of the typical rigors of techno-economic modeling for the use of glycerol as a feed stock, leading typically to unmet expectations. Bacteria produce biosurfactants if grown on carbon sources such as glucose, glycerol, and various vegetable oils. Our research on biosurfactant production by bacteria indicates that glycerol can be used efficiently for biosurfactant production (Rahman et al., 2002).

The considerable interest in biosurfactants in the recent years is also due to their low toxicity, biodegradable nature and specificity, which would be very suitable to meet the European Surfactant Directive. Regulation EC No.: 648/2004 requires clear and precise description of the biodegradability of the surfactant and test methods to give assurance of its aerobic biodegradability. This regulation establishes rules designed to achieve the free movement of detergents and surfactants for detergents in the internal market while, at the same time, ensuring a high degree of protection of the environment and human health.

Surfactants constitute an important class of industrial chemicals and are widely used in almost every sector of modern industry. Most of the commercially available surfactants are chemical surfactants mainly, petroleum-derived. However, rapid advances in biotechnology and increased environmental awareness among consumers combined with expected new environmental legislation has provided further impetus for serious consideration of biological surfactants as possible alternatives to existing products.

Biosurfactant's economic feasibility—what it takes to become a market leader?

As described in the previous section, there is enormous awareness among the consumers these days with regard to sustainability and global warming. The demand for bio-based technologies is ever increasing and “green solutions” are sought for every process. Rhamnolipids have promising properties and fulfill the eco-friendly criteria, one of the main drivers, but are still struggling to become market leaders. The economics of production is a major bottleneck in the outburst of commercialization of rhamnolipids and other biosurfactants (Table 2). There is still no downstream technology economical and convincing enough to recover and purify rhamnolipids at industrial scale. In case of biosurfactant production the downstream processing accounts for 70–80% of the entire production costs.

Table 2

BiosurfactantOriginSupplierST mN/mCMC (%)Cost (£/L)
BioFutureBacterial rhamnolipidBioFuture Ltd. Dublin280.080.02
CitrasolvOrange peelCleveland Biotech Ltd., Teesside300.90.01
EC601Bacterial rhamnolipidEcochem Ltd., Canada290.20.23
EC1800Bacterial consortiumEcochem Ltd., Canada280.040.01
PetrosolvBacterial unknownEnzyme Technologies Inc., USA340.20.01
SaponinPlant barkSigma UK450.10.50

Cost of biosurfactant per liter of solution (diluted and the CMC based cost calculation carried out by Connolly et al., 2010).

The table also gives the origin of biosurfactant along with surface tension (ST) and critical micelle concentration (CMC) values.

It is a no-brainer that in order to gain higher profit at commercial scale it requires access to very cheap feedstock. There are some other key parameters that need thorough consideration in order to make any product economically feasible. Technological fit and process optimization are among the main drivers. Fermentation time is another key to success. Fermentation performance and scale impact process economy as it is directly related to the yield, titer, and productivity. High cost of production especially because of the expensive substrates and down-stream processes makes it difficult to bring down the price of these environment friendly biomolecules. In order to compete with the synthetic detergents or surfactants the cost of production must be brought down to £1.70 per liter which is in itself a challenging task. As there are many barriers in the commercialization of biosurfactants, there seems no dearth of opportunities in this field. Cost comparison of various technologies viz. enzymatic, continuous, shake flask, batch, and fed-batch used for biosurfactant production pinpoint the requirement of innovative methods wherein rhamnolipids can be produced in static conditions to reduce the fermentation cost. The operating costs can be brought down by robust wild-type strains or recombinant mutant strains. Testing the possibility of co-products and/or enzymes is another attractive solution to surge the net profit—for example: esterases released during the production of lipopeptides by Bacillus strain and its recombinants (Sekhon et al., 2011, 2012). Co-products and by-products are value drivers and increase the economic viability of any business. The search of cheap and easily accessible raw material or substrate for biosurfactants production has been going on for years. The utilization of by-products, even if from a different process could be another smart solution—for example: glycerol, which is a by-product of biodiesel production, is available in surplus amount in the global market (Albarelli et al., 2011) which might be a cheap alternative for biosurfactant production.

Rhamnolipids are well-characterized and scientifically proven biosurfactants which are slowly and steadily becoming highly sought after biomolecules. Among other biosurfactants rhamnolipids have the highest number of patents (Table 3) and research publications. However, cost-competitiveness is one of the major factors that is holding rhamnolipids back from becoming the champions of their field. Research needs to be focused on suitable vigorous production strains, cheap substrates and nominal bioreactor technology. The current market price of rhamnolipid (R-95, 95%) is $227/10 mg (Sigma-aldrich) and $200/10 mg (AGAE technologies, USA) calling for strenuous research. Rhamnolipids have favorable applications in various sectors and if made economically sustainable nothing can stop these biomolecules to rule the surface-active compounds market.

Table 3

S. No.Patent or Application No.FiledIssuedTitleInventors
14628030Aug 1984Dec 1986Process for the production of rhamnolipidsKaeppeli and Guerra-Santos
24814272Feb 1985March 1989Process for the biotechnical production of rhamnolipids including rhamnolipids with only one. Beta.-hydroxydecanoic acid residue in the moleculeWagner et al.
34933281March 1987June 1990Method for producing rhamnoseDaniels et al.
44902512Jan 1988Feb 1990Rhamnolipid liposomesIshigami et al.
55417879Sep 1993May 1995Synergistic dual-surfactant detergent composition containing sophoroselipidHall et al.
65455232April 1994Oct 1995Pharmaceutical preparation based on rhamnolipidPiljac and Piljac
75550227May 1994Aug 1996Method for the preparation of rhamnose monohydrate from rhamnolipidsMixich et al.
85466675July 1994Nov 1995Immunological activity of rhamnolipidsPiljac and Piljac
95520839Jan 1995May 1996Laundry detergent composition containing synergistic combination of sophorose lipid and non-ionic surfactantHall et al.
105501966Jan 1995March 1996Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnoseGiani et al.
115658793June 1995Aug 1997Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnoseGiani et al.
125514661Aug 1995May 1996Immunological activity of rhamnolipidsPiljac and Piljac
135767090Jan 1996June 1998Microbially produced rhamnolipids (biosurfactants) for the control of plant pathogenic zoosporic fungiStanghellini et al.
147129218Aug 2000Oct 2006Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regenerationStipcevic et al.
157262171Aug 2000Aug 2007Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmeticsPiljac and Piljac
1620040224905May 2002Nov 2004Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regenerationStipcevic et al.
1720060233935Nov 2003Oct 2006Rhamnolipids in bakery productsHaesendonck and Vanzeveren
187202063Aug 2005April 2007Processes for the production of rhamnolipidsGunther et al.
1920070191292Feb 2006Aug 2007Antimycotic rhamnolipid compositions and related methods of useGandhi et al.
2020070155678Feb 2007July 2007Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmeticsPiljac and Piljac
2120070207930Feb 2007Sep 2007Rhamnolipid compositions and related methods of useGandhi et al.
227968499Feb 2007June 2011Rhamnolipid compositions and related methods of useGandhi and Skebba
2320080213194July 2007Sep 2008Rhamnolipid-based formulationsKeith DeSanto
247985722July 2007July 2011Rhamnolipid-based formulationsKeith DeSanto
2520100249058Oct 2007Sep 2010Feed additive and feedIto et al.
2620090126948Nov 2007May 2009Use of rhamnolipid based formulations for fire suppression and chemical and biological hazardsKeith DeSanto
2720080261891Feb 2008Oct 2008Compositions and methods for using syringopeptin 25A and rhamnolipidsBart C. Weimer
2820090220603May 2009Sep 2009Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmeticsPiljac and Piljac
2920110123623Nov 2010May 2011Rhamnolipid mechanismKeith DeSanto
3020120322751Feb 2011Dec 2012Use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animalsGoran Piljac
3120110257115June 2011Oct 2011Method for treating rhinitis and sinusitis by rhamnolipidsAnton Leighton
3220110306569June 2011Dec 2011Rhamnolipid biosurfactant from Pseudomonas aeruginosa strain NY3 and methods of useYin et al.
338592381June 2011Nov 2013Method for treating rhinitis and sinusitis by rhamnolipidsAnton Leighton
3420110270207July 2011Nov 2011Rhamnolipid based formulationsKeith DeSanto
358183198July 2011May 2012Rhamnolipid-based formulationsKeith DeSanto
3620130130319July 2011May 2013Cells and methods for producing rhamnolipidsSchaffer et al.
3720120255918April 2012Oct 2012Use of rhamnolipids in the water treatment industryDeSanto and Keer
3820130296461May 2013Nov 2013Aqueous coatings and paints incorporating one or more antimicrobial biosurfactants and methods for using sameLakshmi Sadasivan
3920130310330July 2013Nov 2013Method for treating obesityAnton Leighton
408765694July 2013July 2014Method for treating obesityAnton Leighton
4120140080771Nov 2013March 2014Method for treating rhinitis and sinusitis by rhamnolipidsAnton Leighton
4220140148588Nov 2013May 2014Process for the isolation of rhamnolipidsSchilling et al.

A timeline and the major patents and grants obtained on rhamnolipids so far.

Concluding remarks

As the Health and Safety in the bioprocessing become paramount for large scale production there are significant interests in the search for novel non-pathogenic rhamnolipid producers. The numbers of cultured organisms from the environmental samples are only a tiny fraction (0.001%) of the actual microbial diversity. There are significant number of microbial isolates that needs to be explored and exploited for rhamnolipid and other bioproduct manufacturing. Biosurfactant producing probiotic organisms will play a key role in the future of biosurfactant market. Edible emulsifiers from these processes would be applicable to many applications including food, cosmetic, environmental clean-up, biomedical and natural therapy. Rhamnolipid could be a potential alternative for the synthetic surfactant molecules and an important platform chemical cluster with the market value of $2.8 billion in 2023 (Grand View Research Inc., 2014). There is a significant need for the discovery of novel non-pathogenic rhamnolipid producers with enhanced production capacity and efforts to scale up through bioprocess engineering are important to meet the future predictions of biosurfactants market.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    AlbarelliJ. Q.SantosD. T.HolandaM. R. (2011). Energetic and economic evaluation of waste glycerol cogeneration in Brazil. Braz. J. Chem. Eng. 28, 691698. 10.1590/S0104-66322011000400014

  • 2

    ArimaK.KakinumaA.TamuraG. (1968). Surfactin, a crystalline peptide-lipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem. Biophys. Res. Commun. 31, 488494. 10.1016/0006-291X(68)90503-2

  • 3

    AyoubM.AbdullahA. Z. (2012). Critical review on the current scenario and significance of crude glycerol resulting from biodiesel industry towards more sustainable renewable energy industry. Renew. Sust. Energ. Rev. 16, 26712686. 10.1016/j.rser.2012.01.054

  • 4

    ConnollyH. E.RahmanP. K. S. M.BanatI. M.LordR. A. (2010). Resource recovery and reduction of oily hazardous wastes via biosurfactant washing and bioremediation, in Trends in Bioremediation and Phytoremediation, ed GrazynaP. (Trivandrum, India: Research Signpost), 157172.

  • 5

    CostaS. G. V. A. O.NitschkeM.LepineF.DezielE.ContieroJ. (2010). Structure, properties and applications of rhamnolipids produced by Pseudomonas aeruginosa L2-1 from cassava wastewater. Process Biochem. 45, 15111516. 10.1016/j.procbio.2010.05.033

  • 6

    Grand View Research Inc. (2014). Biosurfactants Market by Product (Market Research Report Code: GVR20). Available online at: http://www.grandviewresearch.com/industry-analysis/biosurfactants-industry

  • 7

    KaeppeliO.Guerra-SantosL. (1986). Process for the Production of Rhamnolipids. Patent no. US 4628030 A.

  • 8

    MagalhaesL.NitschkeM. (2013). Antimicrobial activity of rhamnolipids against Listeria monocytogenes and their synergistic interaction with nisin. Food Control. 29, 138142. 10.1016/j.foodcont.2012.06.009

  • 9

    ParryA. J.ParryN. J.PeilowC.StevensonP. S. (2013). Combinations of Rhamnolipids and Enzymes for Improved Cleaning. Patent no. EP 2596087 A1.

  • 10

    PiljacT.PiljacG. (2007). Use of Rhamnolipids as Cosmetics. Patent no. EP 1056462 B1.

  • 11

    RahmanK. S. M.RahmanT. J.KourkoutasY.PetsasI.MarchantR.BanatI. M. (2003). Enhanced bioremediation of n-alkane in petroleum sludge using bacterial consortium amended with rhamnolipid and micronutrients. Bioresour. Technol. 90, 159168. 10.1016/S0960-8524(03)00114-7

  • 12

    RahmanK. S. M.RahmanT. J.McCleanS.MarchantR.BanatI. M. (2002). Rhamnolipid biosurfactant production by strains of Pseudomonas aeruginosa using low-cost raw materials. Biotechnol. Progr. 18, 12771281. 10.1021/bp020071x

  • 13

    RahmanP. K. S. M.GakpeE. (2008). Production, characterization and applications of biosurfactants—review. Biotechnology7, 360370. 10.3923/biotech.2008.360.370

  • 14

    SachdevD. P.CameotraS. S. (2013). Biosurfactants in agriculture. Appl. Microbiol. Biotechnol. 97, 10051016. 10.1007/s00253-012-4641-8

  • 15

    SekhonK. K.KhannaS.CameotraS. S. (2011). Enhanced biosurfactant production through cloning of three genes and role of esterase in biosurfactant release. Microb. Cell. Fact. 10:49. 10.1186/1475-2859-10-49

  • 16

    SekhonK. K.KhannaS.CameotraS. S. (2012). Biosurfactant production and potential correlation with esterase activity. J. Pet. Environ. Biotechnol. 3:133. 10.4172/2157-7463.1000133

  • 17

    SheteA. M.WadhawaG.BanatI. M.ChopadeB. A. (2006). Mapping of patents on bioemulsifier and biosurfactant: a review. J. Sci. Ind. Res. 65, 91115. 10.4172/2157-7463.1000133

  • 18

    WagnerF.SyldatkC.MatulowicU.HofmannH.-J.SeweK.-U.LindorferW. (1989). Process for the Biotechnical Production of Rhamnolipids Including Rhamnolipids with only one β-Hydroxydecanoic Acid Residue in the Molecule. US Patent number: 4814272.

  • 19

    XuQ.NakajimaM.KiuZ.ShiinaT. (2011). Biosurfactants for microbubble preparation and application. Int. J. Mol. Sci. 12, 462475. 10.3390/ijms12010462

Summary

Keywords

biosurfactants, rhamnolipids, market Access, surfactants, sustainability

Citation

Sekhon Randhawa KK and Rahman PKSM (2014) Rhamnolipid biosurfactants—past, present, and future scenario of global market. Front. Microbiol. 5:454. doi: 10.3389/fmicb.2014.00454

Received

23 June 2014

Accepted

11 August 2014

Published

02 September 2014

Volume

5 - 2014

Edited by

Peter Neubauer, Technische Universität Berlin, Germany

Reviewed by

Johannes Scholten, Microbiology, USA; Martin Siemann-Herzberg, University Stuttgart, Germany

Copyright

*Correspondence: ;

This article was submitted to Microbiotechnology, Ecotoxicology and Bioremediation, a section of the journal Frontiers in Microbiology.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics